| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Anti-HIV Agents | 5 | 2019 | 2209 | 1.22 | Why? |
| HIV Infections | 10 | 2019 | 11620 | 1.00 | Why? |
| Food Parasitology | 1 | 2019 | 3 | 0.82 | Why? |
| Immunoglobulins, Intravenous | 3 | 2021 | 2705 | 0.81 | Why? |
| Trematode Infections | 1 | 2019 | 9 | 0.81 | Why? |
| Acquired Immunodeficiency Syndrome | 3 | 2017 | 533 | 0.79 | Why? |
| Breath Holding | 1 | 2018 | 13 | 0.78 | Why? |
| Cerebral Arterial Diseases | 1 | 2018 | 46 | 0.74 | Why? |
| Foodborne Diseases | 1 | 2019 | 89 | 0.73 | Why? |
| AIDS Dementia Complex | 1 | 2018 | 48 | 0.72 | Why? |
| Hepatitis B e Antigens | 1 | 2017 | 99 | 0.65 | Why? |
| HIV-1 | 5 | 2019 | 3365 | 0.60 | Why? |
| Nevirapine | 2 | 2017 | 57 | 0.57 | Why? |
| Interleukin-18 | 1 | 2017 | 328 | 0.56 | Why? |
| Vascular Stiffness | 1 | 2018 | 264 | 0.56 | Why? |
| Herpesvirus 4, Human | 1 | 2018 | 387 | 0.55 | Why? |
| Neglected Diseases | 1 | 2019 | 381 | 0.55 | Why? |
| Receptors, IgG | 1 | 2018 | 578 | 0.54 | Why? |
| Epstein-Barr Virus Infections | 1 | 2018 | 366 | 0.52 | Why? |
| Tenofovir | 1 | 2017 | 449 | 0.51 | Why? |
| Fever of Unknown Origin | 1 | 2014 | 93 | 0.51 | Why? |
| CD4 Lymphocyte Count | 5 | 2019 | 1517 | 0.51 | Why? |
| Immunophenotyping | 1 | 2018 | 1290 | 0.50 | Why? |
| Antiretroviral Therapy, Highly Active | 3 | 2017 | 952 | 0.49 | Why? |
| Severe Acute Respiratory Syndrome | 12 | 2020 | 12361 | 0.49 | Why? |
| Antibodies, Antiphospholipid | 3 | 2020 | 519 | 0.45 | Why? |
| DNA, Viral | 2 | 2019 | 2521 | 0.40 | Why? |
| Hepatitis B | 1 | 2017 | 888 | 0.37 | Why? |
| CD4-CD8 Ratio | 2 | 2019 | 235 | 0.35 | Why? |
| Mass Screening | 2 | 2018 | 8005 | 0.35 | Why? |
| T-Lymphocytes, Cytotoxic | 3 | 2010 | 552 | 0.34 | Why? |
| Delayed Diagnosis | 1 | 2017 | 1529 | 0.33 | Why? |
| Immunologic Factors | 2 | 2020 | 4206 | 0.33 | Why? |
| Lymphocyte Count | 2 | 2020 | 4758 | 0.33 | Why? |
| Diagnostic Tests, Routine | 1 | 2018 | 2643 | 0.33 | Why? |
| Seroconversion | 1 | 2017 | 2515 | 0.32 | Why? |
| SARS Virus | 12 | 2020 | 13021 | 0.32 | Why? |
| Monocytes | 1 | 2018 | 2978 | 0.29 | Why? |
| Antibody-Dependent Enhancement | 2 | 2020 | 413 | 0.27 | Why? |
| CD4-Positive T-Lymphocytes | 4 | 2018 | 4545 | 0.27 | Why? |
| China | 18 | 2021 | 50654 | 0.27 | Why? |
| Antibodies, Neutralizing | 6 | 2020 | 25288 | 0.27 | Why? |
| Immunoglobulin G | 5 | 2020 | 21571 | 0.26 | Why? |
| RNA, Viral | 4 | 2021 | 32276 | 0.25 | Why? |
| Coronavirus Infections | 15 | 2020 | 253789 | 0.24 | Why? |
| Time-to-Treatment | 1 | 2019 | 5883 | 0.23 | Why? |
| Leukocytes, Mononuclear | 4 | 2021 | 2115 | 0.22 | Why? |
| Viral Load | 7 | 2019 | 15850 | 0.22 | Why? |
| Blood Coagulation Factor Inhibitors | 1 | 2020 | 41 | 0.22 | Why? |
| Male | 33 | 2021 | 367725 | 0.21 | Why? |
| Pneumonia, Viral | 14 | 2020 | 243684 | 0.21 | Why? |
| Trematoda | 1 | 2019 | 8 | 0.20 | Why? |
| Adult | 24 | 2021 | 244371 | 0.20 | Why? |
| Bodily Secretions | 1 | 2020 | 109 | 0.20 | Why? |
| Praziquantel | 1 | 2019 | 44 | 0.20 | Why? |
| Models, Biological | 1 | 2017 | 4907 | 0.20 | Why? |
| Tertiary Care Centers | 1 | 2017 | 8248 | 0.19 | Why? |
| Fishes | 1 | 2019 | 99 | 0.19 | Why? |
| Middle Aged | 26 | 2021 | 270681 | 0.19 | Why? |
| Blood Coagulation Factors | 1 | 2020 | 223 | 0.19 | Why? |
| Flexiviridae | 1 | 2017 | 1 | 0.18 | Why? |
| Central Nervous System Bacterial Infections | 1 | 2017 | 5 | 0.18 | Why? |
| Anthelmintics | 1 | 2019 | 104 | 0.18 | Why? |
| Brucella | 1 | 2017 | 14 | 0.18 | Why? |
| Hemofiltration | 1 | 2020 | 155 | 0.18 | Why? |
| Citrus | 1 | 2017 | 29 | 0.18 | Why? |
| Female | 29 | 2021 | 380317 | 0.18 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 2 | 2020 | 8843 | 0.18 | Why? |
| Humans | 50 | 2021 | 930598 | 0.18 | Why? |
| Betacoronavirus | 12 | 2020 | 204454 | 0.17 | Why? |
| Neopterin | 1 | 2018 | 69 | 0.17 | Why? |
| Vagina | 1 | 2020 | 327 | 0.17 | Why? |
| Coinfection | 2 | 2018 | 6820 | 0.17 | Why? |
| Brucellosis | 1 | 2017 | 49 | 0.17 | Why? |
| CD8-Positive T-Lymphocytes | 4 | 2018 | 5837 | 0.17 | Why? |
| Jurkat Cells | 1 | 2017 | 273 | 0.17 | Why? |
| Immunoglobulin Fab Fragments | 1 | 2020 | 556 | 0.17 | Why? |
| Pulse Wave Analysis | 1 | 2018 | 221 | 0.16 | Why? |
| Chromatography, Affinity | 2 | 2017 | 310 | 0.16 | Why? |
| Plant Diseases | 1 | 2017 | 84 | 0.16 | Why? |
| GPI-Linked Proteins | 1 | 2018 | 317 | 0.16 | Why? |
| Half-Life | 1 | 2017 | 298 | 0.16 | Why? |
| Enterovirus D, Human | 1 | 2017 | 96 | 0.16 | Why? |
| Listeriosis | 1 | 2016 | 36 | 0.15 | Why? |
| Immunoglobulin Fc Fragments | 1 | 2020 | 691 | 0.15 | Why? |
| Antibodies, Viral | 7 | 2020 | 51949 | 0.15 | Why? |
| Body Fluids | 1 | 2020 | 451 | 0.15 | Why? |
| Antigens, Viral | 2 | 2011 | 6298 | 0.15 | Why? |
| Pilot Projects | 2 | 2018 | 5182 | 0.15 | Why? |
| Cardiovascular Diseases | 2 | 2020 | 11497 | 0.15 | Why? |
| Critical Illness | 6 | 2021 | 17281 | 0.15 | Why? |
| Lamivudine | 1 | 2017 | 210 | 0.15 | Why? |
| Thromboplastin | 1 | 2018 | 275 | 0.15 | Why? |
| Disease-Free Survival | 1 | 2021 | 1654 | 0.15 | Why? |
| Virus Latency | 1 | 2017 | 251 | 0.15 | Why? |
| Practice Guidelines as Topic | 1 | 2020 | 15421 | 0.15 | Why? |
| Cytokines | 4 | 2020 | 15010 | 0.14 | Why? |
| Triterpenes | 1 | 2017 | 199 | 0.14 | Why? |
| AIDS-Related Opportunistic Infections | 1 | 2017 | 260 | 0.14 | Why? |
| B-Lymphocytes | 2 | 2020 | 4418 | 0.14 | Why? |
| Coronavirus | 2 | 2020 | 18339 | 0.13 | Why? |
| Interleukin-10 | 1 | 2021 | 1409 | 0.13 | Why? |
| Follow-Up Studies | 5 | 2020 | 17020 | 0.13 | Why? |
| Body Composition | 1 | 2017 | 414 | 0.13 | Why? |
| Chromatography, High Pressure Liquid | 1 | 2017 | 669 | 0.13 | Why? |
| Chronic Disease | 2 | 2018 | 5139 | 0.12 | Why? |
| Plasma Exchange | 1 | 2020 | 763 | 0.12 | Why? |
| Enterovirus Infections | 1 | 2017 | 404 | 0.12 | Why? |
| Membrane Glycoproteins | 4 | 2010 | 2273 | 0.12 | Why? |
| HLA-A Antigens | 2 | 2010 | 196 | 0.12 | Why? |
| Ferritins | 1 | 2021 | 2055 | 0.12 | Why? |
| Heparin, Low-Molecular-Weight | 1 | 2020 | 1731 | 0.11 | Why? |
| Immunization | 1 | 2020 | 2019 | 0.11 | Why? |
| Immunodominant Epitopes | 1 | 2016 | 813 | 0.11 | Why? |
| Retrospective Studies | 10 | 2021 | 105322 | 0.11 | Why? |
| Aged | 17 | 2021 | 215776 | 0.11 | Why? |
| Animals | 10 | 2020 | 78931 | 0.11 | Why? |
| Inflammasomes | 1 | 2017 | 710 | 0.10 | Why? |
| Interleukin-6 | 4 | 2021 | 7522 | 0.10 | Why? |
| Dyslipidemias | 1 | 2017 | 791 | 0.10 | Why? |
| Disease Progression | 2 | 2020 | 13580 | 0.10 | Why? |
| Area Under Curve | 1 | 2017 | 2564 | 0.10 | Why? |
| Limit of Detection | 1 | 2017 | 2698 | 0.10 | Why? |
| Young Adult | 7 | 2020 | 93724 | 0.10 | Why? |
| Viremia | 1 | 2017 | 1020 | 0.10 | Why? |
| Kidney | 2 | 2021 | 3648 | 0.10 | Why? |
| Patient Care Management | 1 | 2020 | 1514 | 0.10 | Why? |
| Epitopes, T-Lymphocyte | 2 | 2010 | 2262 | 0.10 | Why? |
| Anti-Retroviral Agents | 1 | 2017 | 1099 | 0.09 | Why? |
| Viral Envelope Proteins | 4 | 2010 | 3539 | 0.09 | Why? |
| Real-Time Polymerase Chain Reaction | 2 | 2019 | 11367 | 0.09 | Why? |
| Polymerase Chain Reaction | 2 | 2020 | 6740 | 0.09 | Why? |
| Dendritic Cells | 1 | 2017 | 1330 | 0.09 | Why? |
| Medicine, Chinese Traditional | 1 | 2020 | 2255 | 0.09 | Why? |
| Thrombophilia | 1 | 2020 | 1935 | 0.09 | Why? |
| Urban Population | 1 | 2018 | 2000 | 0.09 | Why? |
| Epitopes, B-Lymphocyte | 1 | 2016 | 1267 | 0.09 | Why? |
| Genomics | 1 | 2020 | 3118 | 0.09 | Why? |
| Glucocorticoids | 2 | 2020 | 4431 | 0.09 | Why? |
| Neutralization Tests | 5 | 2020 | 6698 | 0.09 | Why? |
| Killer Cells, Natural | 1 | 2018 | 2093 | 0.09 | Why? |
| Molecular Sequence Data | 3 | 2010 | 3198 | 0.09 | Why? |
| Patient Isolation | 2 | 2020 | 3182 | 0.08 | Why? |
| Enzyme-Linked Immunosorbent Assay | 4 | 2011 | 7868 | 0.08 | Why? |
| Mice | 4 | 2020 | 21357 | 0.08 | Why? |
| Genes, MHC Class II | 1 | 2006 | 48 | 0.08 | Why? |
| Blood Coagulation | 1 | 2020 | 2768 | 0.08 | Why? |
| Drug Combinations | 1 | 2017 | 3852 | 0.08 | Why? |
| Blotting, Western | 1 | 2009 | 863 | 0.08 | Why? |
| Genes, MHC Class I | 1 | 2006 | 81 | 0.08 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2017 | 2483 | 0.08 | Why? |
| Case-Control Studies | 3 | 2020 | 17671 | 0.08 | Why? |
| Multivariate Analysis | 1 | 2017 | 5440 | 0.08 | Why? |
| Respiratory Tract Infections | 2 | 2018 | 6817 | 0.08 | Why? |
| Family | 1 | 2020 | 2909 | 0.08 | Why? |
| Prospective Studies | 3 | 2019 | 43301 | 0.08 | Why? |
| Nucleocapsid Proteins | 2 | 2010 | 3120 | 0.08 | Why? |
| Patient Care Team | 1 | 2020 | 3556 | 0.08 | Why? |
| Blood Coagulation Disorders | 1 | 2020 | 2040 | 0.08 | Why? |
| Survival Rate | 1 | 2021 | 9206 | 0.08 | Why? |
| Influenza A Virus, H1N1 Subtype | 1 | 2020 | 2984 | 0.08 | Why? |
| Epitope Mapping | 1 | 2010 | 1240 | 0.07 | Why? |
| Hospitals | 3 | 2020 | 11793 | 0.07 | Why? |
| Hydrolyzable Tannins | 1 | 2004 | 79 | 0.07 | Why? |
| Patient Admission | 1 | 2020 | 5250 | 0.06 | Why? |
| Smoking | 1 | 2017 | 3358 | 0.06 | Why? |
| Drug Therapy, Combination | 1 | 2017 | 7268 | 0.06 | Why? |
| Flow Cytometry | 2 | 2009 | 2393 | 0.06 | Why? |
| T-Lymphocytes | 1 | 2020 | 6670 | 0.06 | Why? |
| Adolescent | 6 | 2020 | 86841 | 0.06 | Why? |
| Cross Reactions | 2 | 2020 | 4374 | 0.06 | Why? |
| Lopinavir | 1 | 2017 | 4308 | 0.06 | Why? |
| Viral Matrix Proteins | 1 | 2010 | 1243 | 0.06 | Why? |
| Pandemics | 13 | 2020 | 389249 | 0.06 | Why? |
| Ritonavir | 1 | 2017 | 4212 | 0.06 | Why? |
| Antibody Specificity | 1 | 2006 | 1328 | 0.06 | Why? |
| Gene Frequency | 1 | 2006 | 1210 | 0.06 | Why? |
| Antithrombin Proteins | 1 | 2020 | 13 | 0.06 | Why? |
| Thrombosis | 2 | 2020 | 7504 | 0.06 | Why? |
| Occupational Exposure | 1 | 2020 | 4742 | 0.05 | Why? |
| Seroepidemiologic Studies | 1 | 2017 | 10017 | 0.05 | Why? |
| Clinical Trials as Topic | 1 | 2020 | 7330 | 0.05 | Why? |
| Anti-Inflammatory Agents | 1 | 2020 | 6153 | 0.05 | Why? |
| Time Factors | 4 | 2020 | 31397 | 0.05 | Why? |
| Aged, 80 and over | 6 | 2021 | 88759 | 0.05 | Why? |
| Virus Diseases | 1 | 2018 | 3779 | 0.05 | Why? |
| Antibodies, Anti-Idiotypic | 1 | 2020 | 93 | 0.05 | Why? |
| Protein S | 1 | 2020 | 150 | 0.05 | Why? |
| Acute Kidney Injury | 1 | 2020 | 5762 | 0.05 | Why? |
| Protein C | 1 | 2020 | 141 | 0.05 | Why? |
| Peptide Fragments | 1 | 2010 | 2075 | 0.05 | Why? |
| Flavonoids | 1 | 2004 | 492 | 0.05 | Why? |
| Risk Factors | 5 | 2020 | 71621 | 0.05 | Why? |
| Anticoagulants | 1 | 2020 | 9563 | 0.05 | Why? |
| Hypertension | 2 | 2020 | 8895 | 0.05 | Why? |
| Amino Acid Sequence | 2 | 2010 | 6049 | 0.05 | Why? |
| Cohort Studies | 2 | 2021 | 36005 | 0.05 | Why? |
| Antibodies, Anticardiolipin | 1 | 2020 | 208 | 0.05 | Why? |
| Sepsis | 1 | 2016 | 3517 | 0.05 | Why? |
| Pentacyclic Triterpenes | 1 | 2017 | 45 | 0.04 | Why? |
| Plants, Medicinal | 1 | 2004 | 622 | 0.04 | Why? |
| Fibrosis | 1 | 2021 | 800 | 0.04 | Why? |
| Biomarkers | 2 | 2020 | 23361 | 0.04 | Why? |
| Immunity, Cellular | 1 | 2010 | 3614 | 0.04 | Why? |
| Caspase 1 | 1 | 2017 | 149 | 0.04 | Why? |
| Spleen | 1 | 2021 | 877 | 0.04 | Why? |
| Coculture Techniques | 1 | 2017 | 258 | 0.04 | Why? |
| Rabbits | 1 | 2020 | 1171 | 0.04 | Why? |
| Cluster Analysis | 2 | 2020 | 3001 | 0.04 | Why? |
| Intensive Care Units | 2 | 2020 | 29594 | 0.04 | Why? |
| Age Factors | 1 | 2018 | 21039 | 0.04 | Why? |
| Spike Glycoprotein, Coronavirus | 6 | 2020 | 37182 | 0.04 | Why? |
| Janus Kinases | 1 | 2020 | 414 | 0.04 | Why? |
| Trachea | 1 | 2021 | 894 | 0.04 | Why? |
| Obesity | 1 | 2017 | 7388 | 0.04 | Why? |
| Cerebrospinal Fluid | 1 | 2017 | 234 | 0.04 | Why? |
| Influenza, Human | 1 | 2020 | 10779 | 0.04 | Why? |
| Child | 3 | 2020 | 70012 | 0.04 | Why? |
| Listeria monocytogenes | 1 | 2016 | 68 | 0.04 | Why? |
| Immunoglobulins | 1 | 2020 | 811 | 0.04 | Why? |
| Diabetes Mellitus | 1 | 2017 | 8207 | 0.03 | Why? |
| Fibrin Fibrinogen Degradation Products | 2 | 2020 | 5993 | 0.03 | Why? |
| Protein Structure, Tertiary | 2 | 2010 | 1565 | 0.03 | Why? |
| Epitopes | 1 | 2006 | 4113 | 0.03 | Why? |
| Child, Hospitalized | 1 | 2018 | 556 | 0.03 | Why? |
| Organ Dysfunction Scores | 1 | 2020 | 1475 | 0.03 | Why? |
| Creatinine | 1 | 2020 | 1443 | 0.03 | Why? |
| Phylogeny | 2 | 2017 | 13341 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| DNA, Bacterial | 1 | 2017 | 835 | 0.03 | Why? |
| Cross-Sectional Studies | 2 | 2020 | 53120 | 0.03 | Why? |
| Vasculitis | 1 | 2020 | 691 | 0.03 | Why? |
| Cells, Cultured | 2 | 2017 | 5835 | 0.03 | Why? |
| Lipopolysaccharides | 1 | 2017 | 848 | 0.03 | Why? |
| Virus Activation | 1 | 2017 | 480 | 0.03 | Why? |
| Antiviral Agents | 3 | 2020 | 41703 | 0.03 | Why? |
| Lung | 1 | 2021 | 31049 | 0.03 | Why? |
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2017 | 581 | 0.03 | Why? |
| Interleukin-1beta | 1 | 2017 | 992 | 0.03 | Why? |
| Adenoviridae | 1 | 2018 | 1151 | 0.03 | Why? |
| Kaplan-Meier Estimate | 1 | 2020 | 4260 | 0.03 | Why? |
| Respiratory Syncytial Virus, Human | 1 | 2018 | 846 | 0.03 | Why? |
| HLA-A2 Antigen | 1 | 2010 | 134 | 0.03 | Why? |
| Mice, Inbred BALB C | 1 | 2020 | 5814 | 0.02 | Why? |
| Autopsy | 1 | 2021 | 3495 | 0.02 | Why? |
| Health Personnel | 1 | 2020 | 29646 | 0.02 | Why? |
| Protein Folding | 1 | 2010 | 270 | 0.02 | Why? |
| Orthomyxoviridae | 1 | 2018 | 1168 | 0.02 | Why? |
| Protein Structure, Quaternary | 1 | 2010 | 455 | 0.02 | Why? |
| Immunity | 1 | 2020 | 2651 | 0.02 | Why? |
| Odds Ratio | 1 | 2020 | 5861 | 0.02 | Why? |
| Immunoglobulin A | 1 | 2020 | 3567 | 0.02 | Why? |
| Respiratory Syncytial Virus Infections | 1 | 2018 | 1234 | 0.02 | Why? |
| Hydrogen Bonding | 1 | 2010 | 599 | 0.02 | Why? |
| Carrier Proteins | 1 | 2010 | 513 | 0.02 | Why? |
| HEK293 Cells | 1 | 2020 | 8394 | 0.02 | Why? |
| Mutation | 1 | 2007 | 12376 | 0.02 | Why? |
| Serologic Tests | 1 | 2020 | 4359 | 0.02 | Why? |
| Models, Molecular | 2 | 2010 | 7616 | 0.02 | Why? |
| Infant, Newborn | 2 | 2018 | 23105 | 0.02 | Why? |
| Macaca mulatta | 1 | 2016 | 3716 | 0.02 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 3633 | 0.02 | Why? |
| Logistic Models | 1 | 2020 | 9089 | 0.02 | Why? |
| Macrophages | 1 | 2017 | 2784 | 0.02 | Why? |
| Chloroquine | 1 | 2020 | 3152 | 0.02 | Why? |
| Outpatients | 1 | 2018 | 3417 | 0.02 | Why? |
| Anti-Bacterial Agents | 2 | 2017 | 10083 | 0.02 | Why? |
| Immunologic Techniques | 1 | 2004 | 71 | 0.02 | Why? |
| Infant | 2 | 2018 | 30274 | 0.02 | Why? |
| Luteolin | 1 | 2004 | 70 | 0.02 | Why? |
| Aging | 1 | 2020 | 3581 | 0.02 | Why? |
| Vaccines, DNA | 1 | 2010 | 871 | 0.02 | Why? |
| Mice, Transgenic | 1 | 2010 | 2739 | 0.02 | Why? |
| Child, Preschool | 2 | 2018 | 36283 | 0.02 | Why? |
| Luciferases | 1 | 2004 | 378 | 0.02 | Why? |
| Cell Line | 2 | 2010 | 12040 | 0.01 | Why? |
| Inpatients | 1 | 2018 | 5161 | 0.01 | Why? |
| Virus Cultivation | 1 | 2004 | 579 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2020 | 11041 | 0.01 | Why? |
| Mice, Inbred C57BL | 1 | 2010 | 5542 | 0.01 | Why? |
| Mass Spectrometry | 1 | 2004 | 1165 | 0.01 | Why? |
| Base Sequence | 1 | 2007 | 3581 | 0.01 | Why? |
| Hospitalization | 2 | 2021 | 54280 | 0.01 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 9335 | 0.01 | Why? |
| Sequence Analysis, DNA | 1 | 2007 | 2830 | 0.01 | Why? |
| Disease Models, Animal | 1 | 2016 | 10998 | 0.01 | Why? |
| Binding Sites | 1 | 2010 | 6201 | 0.01 | Why? |
| Inflammation | 1 | 2020 | 13255 | 0.01 | Why? |
| Radiography | 1 | 2005 | 1576 | 0.01 | Why? |
| Ribavirin | 1 | 2004 | 1182 | 0.01 | Why? |
| Asia | 1 | 2004 | 2399 | 0.01 | Why? |
| Epidemics | 1 | 2017 | 6407 | 0.01 | Why? |
| Hospital Mortality | 1 | 2020 | 22087 | 0.01 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.01 | Why? |
| Kinetics | 1 | 2004 | 3238 | 0.01 | Why? |
| Prevalence | 1 | 2018 | 25773 | 0.01 | Why? |
| Microbial Sensitivity Tests | 1 | 2004 | 2886 | 0.01 | Why? |
| Hong Kong | 1 | 2004 | 3361 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2020 | 25144 | 0.01 | Why? |
| Pregnancy | 1 | 2016 | 23879 | 0.01 | Why? |
| Emergency Service, Hospital | 1 | 2018 | 14232 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.01 | Why? |
| Canada | 1 | 2004 | 6018 | 0.01 | Why? |
| Diagnosis, Differential | 1 | 2005 | 7220 | 0.01 | Why? |
| Oxygen | 1 | 2004 | 3715 | 0.01 | Why? |
| Communicable Diseases, Emerging | 1 | 2004 | 2523 | 0.01 | Why? |
| Viral Vaccines | 1 | 2010 | 7560 | 0.01 | Why? |
| Vero Cells | 1 | 2004 | 14117 | 0.01 | Why? |
| Europe | 1 | 2004 | 12702 | 0.01 | Why? |
| Adrenal Cortex Hormones | 1 | 2004 | 6537 | 0.00 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 13720 | 0.00 | Why? |
| Prognosis | 1 | 2004 | 32490 | 0.00 | Why? |